EPO Patent Application: Protein Design Systems and Methods
Summary
The European Patent Office has published patent application EP2026030717A1 concerning protein design systems and methods. The application was published on March 18, 2026, and includes classifications related to biotechnology and artificial intelligence. The inventors have not yet been designated.
What changed
This document is a publication of a European patent application (EP2026030717A1) for "Protein Design Systems and Methods." The application was published by the European Patent Office (EPO) on March 18, 2026. It includes IPC classifications related to protein chemistry, machine learning, and bioinformatics, indicating a focus on advanced computational methods for biological design.
As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, companies operating in the biotechnology and pharmaceutical sectors should be aware of this publication as it may indicate new technological developments or potential intellectual property claims in the area of protein design. The application is designated for numerous European states.
Source document (simplified)
SYSTEMS AND METHODS FOR PROTEIN DESIGN
Publication EP2026030717A1 Kind: A1 Mar 18, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
C07K 16/00 20060101AFI20260208BHEP G06N 3/02 20060101ALI20260208BHEP G16B 15/20 20190101ALI20260208BHEP C12N 15/10 20060101ALI20260208BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.